Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Marts 2023

Genmab — Marts 2023

Planlagt Fastgjort Låst Flyttet Genmab
499 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bibob
    wrote on sidst redigeret af
    #402

    Gode artikler fra OncLive. https://www.onclive.com/effective-utilization-of-cd38-agents-imids-spur-further-clinical-research-in-relapsed-refractory-myeloma

    1 Reply Last reply
    0
    • B Offline
      B Offline
      bibob
      wrote on sidst redigeret af
      #403

      Just a moment...

      favicon

      (www.onclive.com)

      1 Reply Last reply
      0
      • B Offline
        B Offline
        bibob
        wrote on sidst redigeret af
        #404

        Just a moment...

        favicon

        (www.onclive.com)

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #405

          BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update https://investors.biontech.de/news-releases/news-release-details/biontech-announces-fourth-quarter-and-full-year-2022-financial

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #406

            BioNTech Fourth Quarter and Full Year 2022 Earnings Presentation https://investors.biontech.de/events/event-details/2022-q4-and-full-year-earnings-call

            1 Reply Last reply
            0
            • H Offline
              H Offline
              Hamming
              wrote on sidst redigeret af
              #407

              https://twitter.com/BertrandBio/status/1640308983717134336

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bikube
                wrote on sidst redigeret af
                #408

                Det nærmer sig slutningen på opkøb af egne aktier, de mangler lige at købe de sidste 25 K aktier i løbet af ugen.

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #409

                  Transactions in connection with share buy-back program https://www.proinvestor.com/investornyt/960086/transactions-in-connection-with-share-buy-back-program

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    peter12
                    wrote on sidst redigeret af
                    #410

                    Jeg spurgte chatgpt om bnt322. Tror ikke den er helt gal på den : The two companies plan to use Biontech's innovative mRNA technology platform to develop a new class of antibody therapeutics targeting solid tumors. BNT322 is designed to selectively destroy cancer cells by engaging the immune system in a highly specific manner

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #411

                      Genmab Announces Appointment of Martine van Vugt to Chief Strategy Officer https://ir.genmab.com/news-releases/news-release-details/genmab-announces-appointment-martine-van-vugt-chief-strategy

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #412

                        epcoritamab on the CHMP agenda this week to discuss responses received to Day 120 List of Questions

                        1 Reply Last reply
                        0
                        • SEACOPS Offline
                          SEACOPS Offline
                          SEACOP
                          wrote on sidst redigeret af
                          #413

                          Er der nogen naturlig arvtager (kronprins/prinsesse), som blot rager lidt op?

                          1 Reply Last reply
                          0
                          • StockBullS Offline
                            StockBullS Offline
                            StockBull
                            wrote on sidst redigeret af
                            #414

                            JNJ, AbbVie,

                            1 Reply Last reply
                            0
                            • StockBullS Offline
                              StockBullS Offline
                              StockBull
                              wrote on sidst redigeret af
                              #415

                              Link Preview Image
                              The M&A hunt is on — here are the prime targets

                              Companies with advanced molecular therapies, oncology assets and obesity treatments could be fuel for a dealmaking fire this year.

                              favicon

                              PharmaVoice (www.pharmavoice.com)

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bikube
                                wrote on sidst redigeret af
                                #416

                                Sanofi proposed to acquire Provention Bio for $2,9B in cash at 273% premium.

                                1 Reply Last reply
                                0
                                • royalR Offline
                                  royalR Offline
                                  royal
                                  wrote on sidst redigeret af
                                  #417

                                  Har Abbvie råd til at købe Genmab?

                                  1 Reply Last reply
                                  0
                                  • troldmandenT Offline
                                    troldmandenT Offline
                                    troldmanden
                                    wrote on sidst redigeret af
                                    #418

                                    Tror ikke lige Amanda er så heldig med den "liste" over opkøbs kandidater. Altimmune har lige præsenteret data. Fint vægtab på ca 10%. Men "Most patients experienced nausea and vomiting of mild and moderate severity"

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #419

                                      Ja, AbbVie (ABBV) står over for et af de stejleste patentfrafald i branchen, når Humira mister sin amerikanske eksklusivitet næste år. Analytikere forventer, at virksomheden vil have 69 milliarder dollars i frit cash flow frem til 2024 for at genopbygge sine hylder. Andre firmaer, der forventes at se høje kontanter, er Roche, Bristol Myers og Merck.

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #420

                                        Pfizer

                                        1 Reply Last reply
                                        0
                                        • StockBullS Offline
                                          StockBullS Offline
                                          StockBull
                                          wrote on sidst redigeret af
                                          #421

                                          Humira Main patent expiring: 2023

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper